Moreover, recent studies have revealed compensatory mechanisms of pancreatic cancer to bypass GOT2 dependence,19,21 which prompts us to target resistance mechanisms for improved treatment and to focus on whether fibroblasts mediate resistance to GOT2 silencing in the intact immune system. Here, GOT2 is linked to familial pancreatic carcinoma.